Novel imidazo[4,5-c]quinoline derivatives as LRRK2 inhibitors

The present invention provides novel imidazo[4,5-c]quinoline derivatives of Formula (I), and the pharmaceutically acceptable salts thereof I wherein R

Saved in:
Bibliographic Details
Main Authors Verhoest, Patrick Robert, Brodney, Michael Aaron, Wager, Travis T, Zhang, Yuan, Chen, Jinshan Michael, Reese, Matthew Richard, Coffman, Karen Jean, Stepan, Antonia Friederike, Garnsey, Michelle Renee, Henderson, Jaclyn Louise, Kormos, Bethany Lyn, Rose, Colin Richard, Kurumbail, Ravi G, Galatsis, Paul, Coe, Jotham Wadsworth, Chappie, Thomas Allen, Pettersson, Martin Youngjin, Helal, Christopher John, Martinez-Alsina, Luis Angel, Warmus, Joseph Scott
Format Patent
LanguageEnglish
Published 31.10.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides novel imidazo[4,5-c]quinoline derivatives of Formula (I), and the pharmaceutically acceptable salts thereof I wherein R
Bibliography:Application Number: AU20180230236